Dexycu 517 ug/.005mL
dexamethasone · INJECTION, SUSPENSION · EyePoint Pharmaceuticals US, Inc
No Recall HistoryCurrently in Shortage
Plain English
Dexycu is a injection, suspension containing dexamethasone at 517 ug/.005mL, taken intraocular. Manufactured by EyePoint Pharmaceuticals US, Inc.
Key Facts
- Brand Name
- Dexycu
- Generic Name
- dexamethasone
- NDC Code (Product)
71879-001- Manufacturer
- EyePoint Pharmaceuticals US, Inc
- Strength
- 517 ug/.005mL
- Dosage Form
- INJECTION, SUSPENSION
- Route
- INTRAOCULAR
- Marketing Status
- Application #
- NDA208912
- Drug Class
- Corticosteroid [EPC]
- Marketing Start
- 05/22/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is Dexycu used for?
Dexycu contains dexamethasone. It is a injection, suspension taken intraocular. Consult your doctor for specific uses.
Is Dexycu a controlled substance?
Dexycu is not classified as a controlled substance by the DEA.
What is the generic name for Dexycu?
The generic name for Dexycu is dexamethasone. There are 12 other brand versions of dexamethasone.
What is the NDC code for Dexycu 517 ug/.005mL?
The NDC (National Drug Code) for Dexycu 517 ug/.005mL is 71879-001, listed by EyePoint Pharmaceuticals US, Inc.
Other Dexamethasone Brands
See all →- Dexamethasone6 mg/10054-8183
- Dexamethasone Sodium Phosphate10 mg/mL72485-118
- DEXAMETHASONE4 mg/172789-534
- DEXAMETHASONE2 mg/172888-239
- Dexamethasone Sodium Phosphate4 mg/mL76420-398
- Dexamethasone Sodium Phosphate10 mg/mL76420-399
- Mardex 25 Kit76420-810
- Dexamethasone4 mg/180425-0328
- Hemady20 mg/182111-955
- Dexamethasone1.5 mg/182804-132
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)